)
MetaVia (MTVA) investor relations material
MetaVia Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Offering details and pricing
Up to 919,681 Class A Units (each: 1 share, 1.5 Series C, 1.5 Series D warrants) or 919,681 Class B Units (each: 1 pre-funded warrant, 1.5 Series C, 1.5 Series D warrants) are offered at an assumed price of $8.155 per unit, based on the last Nasdaq close.
Series C warrants are exercisable for five years; Series D for two years and callable under certain conditions; pre-funded warrants have a $0.001 exercise price and no expiration.
The underwriters have a 45-day option to purchase up to 137,952 additional shares and/or 413,856 additional warrants.
Estimated net proceeds are $6.0 million (or $7.0 million if the over-allotment is exercised), assuming no Class B Units are sold and no warrants are exercised.
The offering is underwritten by Ladenburg Thalmann & Co. Inc.
Company overview and business model
Clinical-stage biotechnology company focused on novel pharmaceuticals for cardiometabolic diseases, with lead programs in MASH and obesity.
Lead assets: Vanoglipel (DA-1241), a GPR119 agonist for MASH and T2DM, and DA-1726, a GLP1R/GCGR dual agonist for obesity.
Vanoglipel has completed Phase 2a with positive topline results; DA-1726 is in Phase 1 with positive data and further dose escalation planned.
Four legacy programs are not being advanced and are considered for out-licensing or divestiture.
Financial performance and metrics
As of December 31, 2025 (preliminary, unaudited): cash and equivalents of ~$10.3 million, no debt.
Net loss of $11.0 million for the nine months ended September 30, 2025; accumulated deficit of $146.9 million.
R&D expenses decreased 62.5% year-over-year for the nine months ended September 30, 2025, reflecting lower clinical activity.
Cash runway expected into Q3 2026 with proceeds from this offering.
Next MetaVia earnings date
Next MetaVia earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)